The global hemoglobin testing market size was valued at USD 2.6 billion in 2023, driven by the increasing awareness about blood-related illnesses across the globe. The market size is anticipated to grow at a CAGR of 6.8% during the forecast period of 2024-2032 to achieve a value of USD 4.7 billion by 2032.
A hemoglobin test measures the amount of hemoglobin in your blood. Hemoglobin is a protein in your red blood cells that carries oxygen to your body's organs and tissues and transports carbon dioxide from your organs and tissues back to your lungs. If a hemoglobin test reveals that your hemoglobin level is lower than normal, it means you have a low red blood cell count (anaemia). Anemia can have many different causes, including vitamin deficiencies, bleeding, and chronic diseases.
The hemoglobin testing market is witnessing significant trends driven by innovations in the medical devices sector and a growing demand for improved patient outcomes and cost-effective healthcare solutions. One notable trend is the development of hemoglobin Point of Care (POC) Tests devices, with 12 such devices currently in various stages of development worldwide. These POC tests are expected to receive approval within the next decade, indicating a promising future for quick and convenient hemoglobin testing at the point of care.
Research and development activities in the field of haemoglobin testing is playing a pivotal role in market growth. Notably, the introduction of smartphone technology by a professor at Purdue University's Weldon School of Biomedical Engineering is revolutionizing the industry. This technology allows for noninvasive and instant measurement of blood hemoglobin levels, providing a convenient and efficient diagnostic tool.
Furthermore, indigenous innovations are contributing to the market's evolution. The CSIR-Indian Institute of Toxicology Research (IITR) has introduced 'SenzHb,' a rapid hemoglobin detection test kit that operates on a paper-based platform and delivers results in just 30 seconds. Remarkably, this test kit is cost-effective, making it accessible to a broader population.
In summary, the hemoglobin testing market is shaped by trends such as the development of innovative POC testing devices, the integration of smartphone technology for hemoglobin measurement, and the introduction of cost-effective and rapid testing solutions. These trends collectively drive advancements in hemoglobin testing, offering healthcare providers and patients more efficient and accessible diagnostic options.
Market Breakup by Product Type
Market Breakup by Test Type
Market Breakup by Technology
Market Breakup by End User
Hemoglobin Testing Market by Region
The hemoglobin testing market is experiencing notable growth driven by several key drivers. First and foremost is the rising incidence of anaemia, a condition characterized by low hemoglobin levels in the blood. As the prevalence of anaemia continues to increase, the demand for effective and accessible hemoglobin testing methods becomes crucial in diagnosing and managing this condition.
Furthermore, the development of innovative digital health tools is significantly contributing to market growth. Specifically, the use of smartphone camera technology to measure blood hemoglobin levels represent a groundbreaking advancement. This technology has recently achieved recognition by winning the first phase of a National Institutes of Health (NIH)-funded challenge focused on enhancing maternal health outcomes. By allowing healthcare providers to assess a patient's hemoglobin levels using a simple photo of the patient's lower inner eyelid, this digital health tool offers a convenient and non-invasive method for Hemoglobin testing.
In summary, the haemoglobin testing market is driven by the increasing incidence of anaemia and the emergence of innovative digital health solutions that make hemoglobin testing more accessible and convenient. These drivers collectively contribute to improved healthcare outcomes, especially in the context of maternal health and other medical conditions where hemoglobin levels play a critical role in diagnosis and treatment.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
|Scope of the Report
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Product Type
|Breakup by Test Type
|Breakup by Technology
|Breakup by End User
|Breakup by Region
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Hemoglobin Testing Market Overview
3.1 Global Hemoglobin Testing Market Historical Value (2017-2023)
3.2 Global Hemoglobin Testing Market Forecast Value (2024-2032)
4 Global Hemoglobin Testing Market Landscape
4.1 Global Hemoglobin Testing Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Hemoglobin Testing Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
5 Global Hemoglobin Testing Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Hemoglobin Testing Market Segmentation
6.1 Global Hemoglobin Testing Market by Product Type
6.1.1 Market Overview
6.1.2 Automated Hematology Analyzers
6.1.4 Reagents and Consumables
6.2 Global Hemoglobin Testing Market by Test Type
6.2.1 Market Overview
6.2.2 HbA1c Testing
6.2.3 Blood Gas Testing
6.2.4 Oximetry Testing
6.2.5 Cyanmethemoglobin Testing
6.3 Global Hemoglobin Testing Market by Technology
6.3.1 Market Overview
6.4 Global Hemoglobin Testing Market by End User
6.4.1 Market Overview
6.4.3 Research Centres
6.4.5 Diagnostic Centres
6.4.6 Homecare Settings
6.5 Global Hemoglobin Testing Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Hemoglobin Testing Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Hemoglobin Testing Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Hemoglobin Testing Market
9.1 Market Share by Country
10 Latin America Hemoglobin Testing Market
10.1 Market Share by Country
11 Middle East and Africa Hemoglobin Testing Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.2 Bio-Rad Laboratories,Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.4 F. Hoffmann-La Roche Ltd.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.5 EKF Diagnostics
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.6 Siemens Healthcare GmbH
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.7 Thermo Fisher Scientific Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.8 ACON Laboratories, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.9 BIOMEDOMICS INC.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.10 Hemosure, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.11 Humasis Co., Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.12 Immunostics Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.13 Germaine Laboratories, Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.14 Portea Medical
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.15 LifeSign LLC
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
18 Global Hemoglobin Testing Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 2.6 billion in 2023, driven by increasing geriatric population.
The market is anticipated to grow at a CAGR of 6.8% during the forecast period of 2024-2032, likely to reach a market value of USD 4.7 billion by 2032.
The rising development of innovative hemoglobin testing techniques is a major factor driving the market growth.
The growing demand for improved patient outcomes is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Various products in the market include automated hematology analyzers, point-of-care, reagents and consumables.
Testing types include HbA1c testing, blood gas testing, oximetry testing, cyanmethemoglobin testing.
Hemoglobin testing uses chromatography, immunoassay, spectrophotometry, and electrophoresis, among others.
End users in the market are hospitals, research centres, laboratories, diagnostic centres, and homecare settings, among others.
Key players involved in the market are Abbott, Bio-Rad Laboratories,Inc., Danaher, F. Hoffmann-La Roche Ltd., EKF Diagnostics, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., ACON Laboratories, Inc., BIOMEDOMICS INC., Hemosure, Inc., Humasis Co., Ltd., Immunostics Inc., Germaine Laboratories, Inc., Portea Medical, and LifeSign LLC.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.